Works matching DE "DRUG resistance in cancer cells"
Results: 5000
Cancer Stem Cells.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1110
- By:
- Publication type:
- Article
Cancer Stem Cells: Implications for Cancer Therapy.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1101
- By:
- Publication type:
- Article
Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types.
- Published in:
- Oncology (08909091), 2014, p. 1
- By:
- Publication type:
- Article
Mechanisms of Immunotherapy Resistance in mCRPC: Identifying the Enemy on the Visceral Metastatic Battlefield.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 986
- By:
- Publication type:
- Article
The Urology Perspective on Expanding Androgen-Targeted Treatments for Men With Castration-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 8, p. 702
- By:
- Publication type:
- Article
Targeting the Androgen Receptor Signaling Axis to Reduce Testosterone Levels in Prostate Cancer: How Low Should We Go?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 8, p. 700
- By:
- Publication type:
- Article
Expanding Androgen- and Androgen Receptor Signaling-Directed Therapies for Castration- Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 8, p. 693
- By:
- Publication type:
- Article
Updates on the Management of Breast Cancer Brain Metastases.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 572
- By:
- Publication type:
- Article
Personalized Medicine and Anti-EGFR Antibody Therapy in the Treatment of Metastatic Colorectal Cancer: KRAS and Beyond.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 96
- By:
- Publication type:
- Article
Management of Recurrent EOC: The State of the Art.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 298
- By:
- Publication type:
- Article
Recurrent Epithelial Ovarian Cancer: An Update on Treatment.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 288
- By:
- Publication type:
- Article
New Skin Cancer Target Could Delay Drug Resistance.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 164
- Publication type:
- Article
Chronic Lymphocytic Leukemia With del(17p13.1): A Distinct Clinical Subtype Requiring Novel Treatment Approaches.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1044
- By:
- Publication type:
- Article
Test Your Image IQ.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 9, p. 819
- Publication type:
- Article
The Natural History of Hormone Receptor- Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 8, p. 688
- By:
- Publication type:
- Article
Targeting the Insulin Growth Factor Pathway in Gastrointestinal Cancers.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 518
- By:
- Publication type:
- Article
Drug Essentials Cabazitaxel, a Taxane for Men With Hormone-Refractory Metastatic Prostate Cancer.
- Published in:
- Oncology (08909091), 2010, p. 46
- By:
- Publication type:
- Article
Structural basis for cisplatin DNA damage tolerance by human polymerase ? during cancer chemotherapy.
- Published in:
- Nature Structural & Molecular Biology, 2012, v. 19, n. 6, p. 628, doi. 10.1038/nsmb.2295
- By:
- Publication type:
- Article
Study focuses on mechanism of olaparib resistance in prostate cancer.
- Published in:
- Urology Times, 2021, v. 49, n. 10, p. 24
- By:
- Publication type:
- Article
Checkpoint inhibitor AEs highlight importance of team-based care.
- Published in:
- 2021
- Publication type:
- Proceeding
CTC mutations may predict hormone therapy outcomes in mCRPC.
- Published in:
- Urology Times, 2021, v. 49, n. 5, p. 22
- By:
- Publication type:
- Article
Onvansertib is active in patients with abiraterone-resistant prostate cancer: More than one-third of patients undergoing treatment had disease control at 12 weeks.
- Published in:
- Urology Times, 2021, v. 49, n. 3, p. 10
- By:
- Publication type:
- Article
Clinical Updates. DHEA levels may predict response to advanced PCa agent.
- Published in:
- Urology Times, 2014, v. 42, n. 11, p. 11
- By:
- Publication type:
- Article
Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 2, p. 53, doi. 10.1007/s40267-024-01050-3
- By:
- Publication type:
- Article
Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Coamplification with Colocalization of the Human Epidermal Growth Factor Receptor 2 and Centromeric-17 Signals on Fluorescence In Situ Hybridization in Invasive Breast Carcinoma: An Exceedingly Rare Finding.
- Published in:
- Journal of Postgraduate Medicine, 2016, v. 62, n. 3, p. 210, doi. 10.4103/0022-3859.186394
- By:
- Publication type:
- Article
Low‐risk gestational trophoblastic neoplasia – 20 years experience of a state registry.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2024, v. 64, n. 3, p. 223, doi. 10.1111/ajo.13772
- By:
- Publication type:
- Article
Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC).
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2017, v. 57, n. 4, p. 458, doi. 10.1111/ajo.12622
- By:
- Publication type:
- Article
Up-regulation of P-glycoprotein expression by catalase via JNK activation in HepG2 cells.
- Published in:
- Redox Report, 2006, v. 11, n. 4, p. 173, doi. 10.1179/135100006X116682
- By:
- Publication type:
- Article
Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin.
- Published in:
- Macromolecular Chemistry & Physics, 2018, v. 219, n. 23, p. N.PAG, doi. 10.1002/macp.201800352
- By:
- Publication type:
- Article
Development of Natural‐Product‐Inspired ABCB1 Inhibitors Through Regioselective Tryptophan C3‐Benzylation.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 63, p. 1, doi. 10.1002/chem.202401782
- By:
- Publication type:
- Article
Unraveling and Overcoming Platinum Drug‐Resistant Cancer Tumors with DNA Nanostructures.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 2, p. 1, doi. 10.1002/adfm.202208797
- By:
- Publication type:
- Article
Instant Intracellular Delivery of miRNA via Photothermal Effect Induced on Plasmonic Pyramid Arrays.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 9, p. 1, doi. 10.1002/adfm.202107999
- By:
- Publication type:
- Article
ROS‐Catalytic Transition‐Metal‐Based Enzymatic Nanoagents for Tumor and Bacterial Eradication.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 1, p. 1, doi. 10.1002/adfm.202107530
- By:
- Publication type:
- Article
Photodynamic Therapy: Unprecedented Theranostic LaB<sub>6</sub> Nanocubes‐Mediated NIR‐IIb Photodynamic Therapy to Conquer Hypoxia‐Induced Chemoresistance (Adv. Funct. Mater. 36/2020).
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 36, p. 1, doi. 10.1002/adfm.202002940
- By:
- Publication type:
- Article
Unprecedented Theranostic LaB<sub>6</sub> Nanocubes‐Mediated NIR‐IIb Photodynamic Therapy to Conquer Hypoxia‐Induced Chemoresistance.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 36, p. 1, doi. 10.1002/adfm.202002940
- By:
- Publication type:
- Article
Biomimetic, Hypoxia‐Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co‐Targeting of Therapy‐Induced Bone Marrow Niches.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 12, p. 1, doi. 10.1002/adfm.202000309
- By:
- Publication type:
- Article
Smart Supramolecular "Trojan Horse"‐Inspired Nanogels for Realizing Light‐Triggered Nuclear Drug Influx in Drug‐Resistant Cancer Cells.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 13, p. N.PAG, doi. 10.1002/adfm.201807772
- By:
- Publication type:
- Article
Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids.
- Published in:
- Journal of Computer-Aided Molecular Design, 2014, v. 28, n. 7, p. 751, doi. 10.1007/s10822-014-9756-9
- By:
- Publication type:
- Article
2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein.
- Published in:
- Journal of Computer-Aided Molecular Design, 2013, v. 27, n. 2, p. 161, doi. 10.1007/s10822-013-9635-9
- By:
- Publication type:
- Article
Lost at SCLC: a review of potential platinum sensitizers.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 4, p. 1573, doi. 10.1007/s10555-024-10207-5
- By:
- Publication type:
- Article
Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 3, p. 981, doi. 10.1007/s10555-024-10177-8
- By:
- Publication type:
- Article
Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 293, doi. 10.1007/s10555-024-10170-1
- By:
- Publication type:
- Article
Preface.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 3, doi. 10.1007/s10555-024-10180-z
- By:
- Publication type:
- Article
Clusterin: a marker and mediator of chemoresistance in colorectal cancer.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 379, doi. 10.1007/s10555-024-10173-y
- By:
- Publication type:
- Article
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 321, doi. 10.1007/s10555-024-10171-0
- By:
- Publication type:
- Article
Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 363, doi. 10.1007/s10555-023-10154-7
- By:
- Publication type:
- Article
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 457, doi. 10.1007/s10555-023-10162-7
- By:
- Publication type:
- Article
Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 2, p. 575, doi. 10.1007/s10555-021-09959-1
- By:
- Publication type:
- Article
Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer.
- Published in:
- Cancer & Metastasis Reviews, 2020, v. 39, n. 3, p. 825, doi. 10.1007/s10555-020-09910-w
- By:
- Publication type:
- Article